BACKGROUND: Acute allograft rejection is dependent on adaptive immunity, but it is unclear whether the same is true for chronic rejection. Here we asked whether innate immunity alone is sufficient for causing chronic rejection of mouse cardiac allografts. METHODS: We transplanted primarily vascularized cardiac grafts to recombinase activating gene-knockout (RAG(-/-)) mice that lack T and B cells but have an intact innate immune system. Recipients were left unmanipulated, received adjuvants that stimulate innate immunity, or were reconstituted with B-1 lymphocytes to generate natural IgM antibodies. In a second model, we transplanted cardiac allografts to mice that lack secondary lymphoid tissues (splenectomized aly/aly recipients) and studied the effect of NK cell inactivation on T cell-mediated chronic rejection. RESULTS: Acute cardiac allograft rejection was not observed in any of the recipients. Histological analysis of allografts harvested 50 to 90 days after transplantation to RAG(-/-) mice failed to identify chronic vascular or parenchymal changes beyond those observed in control syngeneic grafts. Chronic rejection of cardiac allografts parked in splenectomized aly/aly mice was observed only after the transfer of exogenously activated T cells. NK inactivation throughout the experiment, or during the parking period alone, reduced the severity of T cell-dependent chronic rejection. CONCLUSIONS: The innate immune system alone is not sufficient for causing chronic rejection. NK cells predispose healed allografts to T cell-dependent chronic rejection and may contribute to chronic allograft pathology.
BACKGROUND: Acute allograft rejection is dependent on adaptive immunity, but it is unclear whether the same is true for chronic rejection. Here we asked whether innate immunity alone is sufficient for causing chronic rejection of mouse cardiac allografts. METHODS: We transplanted primarily vascularized cardiac grafts to recombinase activating gene-knockout (RAG(-/-)) mice that lack T and B cells but have an intact innate immune system. Recipients were left unmanipulated, received adjuvants that stimulate innate immunity, or were reconstituted with B-1 lymphocytes to generate natural IgM antibodies. In a second model, we transplanted cardiac allografts to mice that lack secondary lymphoid tissues (splenectomized aly/aly recipients) and studied the effect of NK cell inactivation on T cell-mediated chronic rejection. RESULTS: Acute cardiac allograft rejection was not observed in any of the recipients. Histological analysis of allografts harvested 50 to 90 days after transplantation to RAG(-/-) mice failed to identify chronic vascular or parenchymal changes beyond those observed in control syngeneic grafts. Chronic rejection of cardiac allografts parked in splenectomized aly/alymice was observed only after the transfer of exogenously activated T cells. NK inactivation throughout the experiment, or during the parking period alone, reduced the severity of T cell-dependent chronic rejection. CONCLUSIONS: The innate immune system alone is not sufficient for causing chronic rejection. NK cells predispose healed allografts to T cell-dependent chronic rejection and may contribute to chronic allograft pathology.
Authors: A W Bingaman; J Ha; S Y Waitze; M M Durham; H R Cho; C Tucker-Burden; R Hendrix; S R Cowan; T C Pearson; C P Larsen Journal: J Immunol Date: 2000-03-15 Impact factor: 5.422
Authors: Geetha Chalasani; Zhenhua Dai; Bogumila T Konieczny; Fady K Baddoura; Fadi G Lakkis Journal: Proc Natl Acad Sci U S A Date: 2002-04-30 Impact factor: 11.205
Authors: Ming Zhang; William G Austen; Isaac Chiu; Elisabeth M Alicot; Rachel Hung; Minghe Ma; Nicola Verna; Min Xu; Herbert B Hechtman; Francis D Moore; Michael C Carroll Journal: Proc Natl Acad Sci U S A Date: 2004-03-03 Impact factor: 11.205
Authors: Kim G Hankey; Cinthia B Drachenberg; John C Papadimitriou; David K Klassen; Benjamin Philosophe; Steven T Bartlett; Veronika Groh; Thomas Spies; Dean L Mann Journal: Transplantation Date: 2002-01-27 Impact factor: 4.939
Authors: Daniel Zecher; Qi Li; Martin H Oberbarnscheidt; Anthony J Demetris; Warren D Shlomchik; David M Rothstein; Fadi G Lakkis Journal: J Immunol Date: 2010-05-14 Impact factor: 5.422
Authors: Tengfang Li; Zhongqiang Zhang; Joe G Bartolacci; Gaelen K Dwyer; Quan Liu; Lisa R Mathews; Murugesan Velayutham; Anna S Roessing; Yoojin C Lee; Helong Dai; Sruti Shiva; Martin H Oberbarnscheidt; Jenna L Dziki; Steven J Mullet; Stacy G Wendell; James D Wilkinson; Steven A Webber; Michelle Wood-Trageser; Simon C Watkins; Anthony J Demetris; George S Hussey; Stephen F Badylak; Hēth R Turnquist Journal: J Clin Invest Date: 2020-10-01 Impact factor: 14.808
Authors: Leo W Buss; Christopher Anderson; Erica Westerman; Chad Kritzberger; Monita Poudyal; Maria A Moreno; Fadi G Lakkis Journal: PLoS One Date: 2012-11-08 Impact factor: 3.240
Authors: Julia C Arciero; Andrew Maturo; Anirudh Arun; Byoung Chol Oh; Gerald Brandacher; Giorgio Raimondi Journal: Front Immunol Date: 2016-11-07 Impact factor: 7.561